396 related articles for article (PubMed ID: 19392788)
21. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition.
Van der Walt A; Stankovich J; Bahlo M; Taylor BV; Van der Mei IA; Foote SJ; Rubio JP; Kilpatrick TJ; Butzkueven H
Mult Scler; 2011 Mar; 17(3):344-52. PubMed ID: 21149397
[TBL] [Abstract][Full Text] [Related]
23. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.
Cournu-Rebeix I; Génin E; Leray E; Babron MC; Cohen J; Gout C; Alizadeh M; Perdry H; Semana G; Brassat D; Clerget-Darpoux F; Yaouanq J; Edan G; Rosenheim M; Fontaine B
Genes Immun; 2008 Sep; 9(6):570-4. PubMed ID: 18615093
[TBL] [Abstract][Full Text] [Related]
24. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
[TBL] [Abstract][Full Text] [Related]
25. No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
Handel AE; De Luca GC; Morahan J; Handunnetthi L; Sadovnick AD; Ebers GC; Ramagopalan SV
J Neuroimmunol; 2010 Jun; 223(1-2):120-3. PubMed ID: 20394989
[TBL] [Abstract][Full Text] [Related]
26. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
J Neurol Sci; 2010 Nov; 298(1-2):96-100. PubMed ID: 20810130
[TBL] [Abstract][Full Text] [Related]
27. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.
Mastaglia FL; Needham M; Scott A; James I; Zilko P; Day T; Kiers L; Corbett A; Witt CS; Allcock R; Laing N; Garlepp M; Christiansen FT
Neuromuscul Disord; 2009 Nov; 19(11):763-5. PubMed ID: 19720533
[TBL] [Abstract][Full Text] [Related]
28. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.
Ballerini C; Guerini FR; Rombolà G; Rosati E; Massacesi L; Ferrante P; Caputo D; Talamanca LF; Naldi P; Liguori M; Alizadeh M; Momigliano-Richiardi P; D'Alfonso S
J Neuroimmunol; 2004 May; 150(1-2):178-85. PubMed ID: 15081263
[TBL] [Abstract][Full Text] [Related]
29. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami.
Harbo HF; Utsi E; Lorentzen AR; Kampman MT; Celius EG; Myhr KM; Lie BA; Mellgren SI; Thorsby E
Tissue Antigens; 2007 Apr; 69(4):299-304. PubMed ID: 17389012
[TBL] [Abstract][Full Text] [Related]
30. Genetic association of the major histocompatibility complex with rheumatoid arthritis implicates two non-DRB1 loci.
Vignal C; Bansal AT; Balding DJ; Binks MH; Dickson MC; Montgomery DS; Wilson AG
Arthritis Rheum; 2009 Jan; 60(1):53-62. PubMed ID: 19116923
[TBL] [Abstract][Full Text] [Related]
31. HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia.
Wu JS; James I; Qiu W; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
J Neuroimmunol; 2010 Feb; 219(1-2):109-13. PubMed ID: 20006387
[TBL] [Abstract][Full Text] [Related]
32. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
[TBL] [Abstract][Full Text] [Related]
33. HLA-DR15 is associated with lower age at onset in multiple sclerosis.
Masterman T; Ligers A; Olsson T; Andersson M; Olerup O; Hillert J
Ann Neurol; 2000 Aug; 48(2):211-9. PubMed ID: 10939572
[TBL] [Abstract][Full Text] [Related]
34. The HLA locus and multiple sclerosis in Sicily.
Brassat D; Salemi G; Barcellos LF; McNeill G; Proia P; Hauser SL; Oksenberg JR; Savettieri G
Neurology; 2005 Jan; 64(2):361-3. PubMed ID: 15668443
[TBL] [Abstract][Full Text] [Related]
35. The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease.
Yang R; Cui Z; Zhao J; Zhao MH
Clin Immunol; 2009 Nov; 133(2):245-50. PubMed ID: 19654074
[TBL] [Abstract][Full Text] [Related]
36. High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis.
Shahbazi M; Roshandel D; Ebadi H; Fathi D; Zamani M; Boghaee M; Mohammadhoseeeni M; Rshaidbaghan A; Bakhshandeh A; Shahbazi S
Clin Immunol; 2010 Oct; 137(1):134-8. PubMed ID: 20594918
[TBL] [Abstract][Full Text] [Related]
37. Genetic predisposition to multiple sclerosis as revealed by immunoprinting.
Epplen C; Jäckel S; Santos EJ; D'Souza M; Poehlau D; Dotzauer B; Sindern E; Haupts M; Rüde KP; Weber F; Stöver J; Poser S; Gehler W; Malin JP; Przuntek H; Epplen JT
Ann Neurol; 1997 Mar; 41(3):341-52. PubMed ID: 9066355
[TBL] [Abstract][Full Text] [Related]
38. HLA-DRB1 alleles and Henoch-Schönlein purpura: susceptibility and severity of disease.
Soylemezoglu O; Peru H; Gonen S; Cetinyurek A; Buyan N
J Rheumatol; 2008 Jun; 35(6):1165-8. PubMed ID: 18412308
[TBL] [Abstract][Full Text] [Related]
39. Maternal - offspring HLA-DRB1 compatibility in multiple sclerosis.
Willer CJ; Dyment DA; Sadovnick AD; Ebers GC
Tissue Antigens; 2005 Jul; 66(1):44-7. PubMed ID: 15982256
[TBL] [Abstract][Full Text] [Related]
40. HLA associations with multiple sclerosis in Greece.
Kouri I; Papakonstantinou S; Bempes V; Vasiliadis HS; Kyritsis AP; Pelidou SH
J Neurol Sci; 2011 Sep; 308(1-2):28-31. PubMed ID: 21741664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
